 |
|
Anticoagulation of Pregnant Women With Mechanical Heart Valves
Jeffrey S. Ginsberg, MD, FRCPC;
Wee Shian Chan, MD;
Shannon M. Bates, MDCM;
Scott Kaatz, DO
Arch Intern Med. 2003;163:694-698.
The management of pregnant women with mechanical heart valves is challenging. Recently, based on small numbers of patients and poor-quality data, correspondence from Aventis Pharmaceuticals Inc has described treatment "failures" and concerns about teratogenicity with the use of the low-molecular-weight heparin (LMWH) enoxaparin. The company issued a "Warning" that enoxaparin should not be used in patients with prosthetic heart valves and a "Precaution" about potential teratogenicity. This has created a huge problem for physicians managing pregnant women with prosthetic heart valves because the alternatives, unfractionated heparin and warfarin, are problematic. There have been case reports of failures (including death from thrombosed valves) with unfractionated heparin, whereas the package insert for warfarin states that the drug is contraindicated during pregnancy because of potential teratogenicity. Initially, LMWHs appeared suitable for pregnant patients with prosthetic heart valves. Unfortunately, the company correspondence, presumably supported by the Food and Drug Administration (FDA), raises medicolegal concerns with use of any LMWH. We believe that pharmaceutical companies and the FDA should not endorse scientifically unsupported claims that eliminate acceptable therapeutic options. This correspondence has created considerable confusion among patients and treating physicians and is likely to lead to frivolous lawsuits and preclude the performance of properly designed trials in pregnant women. We believe a consensus conference among experts in the field to identify key unresolved issues and a commitment by the FDA and industry to perform appropriate studies are now critical.
From the Departments of Medicine, McMaster University, Hamilton, Ontario (Drs Ginsberg and Bates), University of Toronto, Toronto, Ontario (Dr Chan), and Henry Ford Hospital, Detroit, Mich (Dr Kaatz). Dr Kaatz has received research funding from Aventis Pharmaceuticals Inc, Roche Diagnostics, DuPont Pharma Pharmaceuticals, Astra-Zeneca, Merck, Sandoz, and NPS, and serves as a consultant for Astra Zeneca and Aventis Pharmaceuticals Inc.
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati
What's this?
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
|
Thrombosis of mechanical valve prosthesis in patient with recent Caesarean delivery
Pastore et al.
Eur J Echocardiogr 2009;10:716-717.
ABSTRACT
| FULL TEXT
2008 Focused Update Incorporated Into the ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1998 Guidelines for the Management of Patients With Valvular Heart Disease): Endorsed by the Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons
2006 WRITING COMMITTEE MEMBERS et al.
Circulation 2008;118:e523-e661.
FULL TEXT
2008 Focused Update Incorporated Into the ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1998 Guidelines for the Management of Patients With Valvular Heart Disease) Endorsed by the Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons
Bonow et al.
J Am Coll Cardiol 2008;52:e1-e142.
FULL TEXT
Pregnancy in women with valvular heart disease
Stout and Otto
Heart 2007;93:552-558.
ABSTRACT
| FULL TEXT
ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1998 Guidelines for the Management of Patients With Valvular Heart Disease) Developed in Collaboration With the Society of Cardiovascular Anesthesiologists Endorsed by the Society for Cardiovascular Angiography and Interventions and the Society of Thoracic Surgeons
Bonow et al.
J Am Coll Cardiol 2006;48:e1-e148.
FULL TEXT
ACC/AHA 2006 Practice Guidelines for the Management of Patients With Valvular Heart Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1998 Guidelines for the Management of Patients With Valvular Heart Disease) Developed in Collaboration With the Society of Cardiovascular Anesthesiologists Endorsed by the Society for Cardiovascular Angiography and Interventions and the Society of Thoracic Surgeons
Bonow et al.
J Am Coll Cardiol 2006;48:598-675.
FULL TEXT
Report of the National Heart, Lung, and Blood Institute Working Group on Research in Adult Congenital Heart Disease
Williams et al.
J Am Coll Cardiol 2006;47:701-707.
ABSTRACT
| FULL TEXT
Pregnancy in women with congenital heart disease: the importance of evaluation and counselling
Stout
Heart 2005;91:713-714.
ABSTRACT
| FULL TEXT
Single-Arm Study of Bridging Therapy With Low-Molecular-Weight Heparin for Patients at Risk of Arterial Embolism Who Require Temporary Interruption of Warfarin
Kovacs et al.
Circulation 2004;110:1658-1663.
ABSTRACT
| FULL TEXT
Anticoagulation in Pregnant Women With Prosthetic Heart Valves
Elkayam et al.
J CARDIOVASC PHARMACOL THER 2004;9:107-115.
ABSTRACT
Pregnancy in heart disease
Thorne
Heart 2004;90:450-456.
FULL TEXT
Anticoagulation of Pregnant Women With Mechanical Heart Valves Using Low-Molecular-Weight Heparin
Bauersachs and Lindhoff-Last
Arch Intern Med 2003;163:2788-2789.
FULL TEXT
Perioperative Management of Patients Receiving Oral Anticoagulants
Kearon and Hirsh
Arch Intern Med 2003;163:2532-2533.
FULL TEXT
Anticoagulation With Prosthetic Cardiac Valves
Topol
Arch Intern Med 2003;163:2251-2252.
FULL TEXT
Thrombotic Disorders: Diagnosis and Treatment
Schafer et al.
ASH Education Book 2003;2003:520-539.
ABSTRACT
| FULL TEXT
|
